| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/23/2000 | EP1029536A1 Buccal non-polar spray |
| 08/23/2000 | EP1029530A1 Use of 3-substituted stilbene derivatives as deodorizing active principles in cosmetic compositions |
| 08/23/2000 | EP1029456A1 Foods for preventing vomiting |
| 08/23/2000 | EP1029246A1 A method and device for preventing immunoglobulin degradation in external secretions |
| 08/23/2000 | EP1029080A1 Human blood bacterium |
| 08/23/2000 | EP1029070A1 Transfecting peptide vector, composition containing same and applications |
| 08/23/2000 | EP1029062A1 Inhibition of human immunodeficiency virus (hiv-1) replication |
| 08/23/2000 | EP1029058A1 Dna demethylase, therapeutic and diagnostic uses thereof |
| 08/23/2000 | EP1029050A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis |
| 08/23/2000 | EP1028991A1 Strictly alternating poly(alkylene oxide ether) copolymers |
| 08/23/2000 | EP1028977A2 Bifidus stimulating peptides |
| 08/23/2000 | EP1028969A2 New sophoroselipids, method for their production and use |
| 08/23/2000 | EP1028964A1 Thienopyrimidine and thienopyridine derivatives useful as anticancer agents |
| 08/23/2000 | EP1028962A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 08/23/2000 | EP1028961A1 Pleuromutilin derivatives as antimicrobials |
| 08/23/2000 | EP1028958A1 Arylpiperazines as serotonin reuptake inhibitors and 5-ht1d alpha antagonists |
| 08/23/2000 | EP1028957A1 Piperidine derivatives and their use as tachykinin antagonists |
| 08/23/2000 | EP1028956A1 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 08/23/2000 | EP1028955A1 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 08/23/2000 | EP1028954A1 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 08/23/2000 | EP1028953A1 Aromatic heterocyclic compounds as anti-inflammatory agents |
| 08/23/2000 | EP1028951A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors |
| 08/23/2000 | EP1028948A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists |
| 08/23/2000 | EP1028947A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type |
| 08/23/2000 | EP1028946A1 Indazole bioisostere replacement of catechol in therapeutically active compounds |
| 08/23/2000 | EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents |
| 08/23/2000 | EP1028942A2 Dipeptide nitriles |
| 08/23/2000 | EP1028941A2 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 08/23/2000 | EP1028756A1 Water soluble paclitaxel derivatives |
| 08/23/2000 | EP1028741A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 08/23/2000 | EP1028736A1 Bovine teat dip |
| 08/23/2000 | EP1028734A1 $i(SPECIFIC) STEADY-STATE R-TYPE Ca?2+ CHANNEL BLOCKERS AND USE THEREOF |
| 08/23/2000 | EP1028733A1 Use of mixtures of active agents containing phytostenol for producing hypocholesteraemic preparations |
| 08/23/2000 | EP1028732A1 Use of selected phytostenol esters for producing hypocholesteraemic preparations |
| 08/23/2000 | EP1028731A2 Stable antiandrogenic gel composition |
| 08/23/2000 | EP1028730A1 Compositions of lipid lowering agents |
| 08/23/2000 | EP1028729A2 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 08/23/2000 | EP1028728A1 Use of quinapril for treating myocardial ischemia and angina |
| 08/23/2000 | EP1028727A1 Skin penetration enhancing components |
| 08/23/2000 | EP1028726A1 Method and composition for treatment of sexual dysfunction |
| 08/23/2000 | EP1028725A1 Application of vasopressin antagonists for treating disturbances or illnesses of the inner ear |
| 08/23/2000 | EP1028724A1 Transdermal delivery of 3,4-diarylchromans |
| 08/23/2000 | EP1028722A1 Pharmaceutically active composition containing artemisinine and/or a derivative of artemisinine |
| 08/23/2000 | EP1028721A1 $i(N,N')-BIS(SULFONYL)HYDRAZINES USEFUL AS ANTINEOPLASTIC AGENTS |
| 08/23/2000 | EP1028720A1 Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| 08/23/2000 | EP1028719A1 Treatment of attention deficit hyperactivity disorder and narcolepsy |
| 08/23/2000 | EP1028718A2 Extended release formulation containing venlafaxin |
| 08/23/2000 | EP1028717A2 Unsubstituted polydiallylamine for treating hypercholesterolemia |
| 08/23/2000 | EP1028716A1 Method for treating and preventing heart failure and ventricular dilatation |
| 08/23/2000 | EP1028710A1 Topical compositions for nsai drug delivery |
| 08/23/2000 | EP1028709A1 Novel once-a-day controlled release sulfonylurea formulation |
| 08/23/2000 | EP1028708A1 Topical compositions for prostaglandin e 1? delivery |
| 08/23/2000 | EP1028707A1 Sustained release ophthalmic compositions containing water soluble medicaments |
| 08/23/2000 | EP1028705A1 Uses of d-xylose, the esters thereof and oligosaccharides containing xylose for improving the functionality of epidermal cells |
| 08/23/2000 | EP1028690A2 Luteinising hormone antagonists useful for treatment of estrogen deficiencies, or as a contraceptive |
| 08/23/2000 | EP1028682A1 Transdermal propentofylline compositions for the treatment of alzheimer's disease |
| 08/23/2000 | EP1028624A1 Use of exochelins in the preservation of organs for transplant |
| 08/23/2000 | EP0960139A4 Elastomer treatment process to decrease peroxide levels |
| 08/23/2000 | EP0861228B1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 08/23/2000 | EP0844873A4 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 08/23/2000 | EP0821668B1 Derivatives of succinamide and their use as metalloproteinase inhibitor |
| 08/23/2000 | EP0805795B1 Novel aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides |
| 08/23/2000 | EP0752860B1 Androstanes and pregnanes for allosteric modulation of gaba receptor |
| 08/23/2000 | EP0729473B1 Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use |
| 08/23/2000 | EP0723547B1 Boronated metalloporphyrins and diagnostic methods |
| 08/23/2000 | EP0711289B1 Piperazine compounds used in therapy |
| 08/23/2000 | EP0708772B1 IMIDAZO [4,5-c]PYRIDIN-4-AMINES |
| 08/23/2000 | EP0706390A4 Enhancing performance capacity by sparing muscle glycogen with medium chain fatty acids |
| 08/23/2000 | EP0698023B1 Fibrinogen receptor antagonists |
| 08/23/2000 | EP0674642B1 Pyrazolopyrimidines as crf antagonists |
| 08/23/2000 | EP0674506B1 Controlled release growth hormone containing microspheres |
| 08/23/2000 | EP0666844B1 Inhibitors of farnesyl-protein transferase |
| 08/23/2000 | EP0658159B1 Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors |
| 08/23/2000 | EP0640072B1 Derivatives of pyridine as hydroxylase and lyase inhibitors |
| 08/23/2000 | EP0637297B1 Compounds having selectivity for retinoid x receptors |
| 08/23/2000 | CN1264427A Osteoprotegernin binding proteins and receptors |
| 08/23/2000 | CN1264387A Nucleotide analog composition and synthesis method thereof |
| 08/23/2000 | CN1264385A Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 08/23/2000 | CN1264384A Fused 1,2,4-thiadiazine derivatives, their preparation method and use |
| 08/23/2000 | CN1264383A Salts of optically active sulfoxide derivative |
| 08/23/2000 | CN1264382A Novel compounds |
| 08/23/2000 | CN1264381A 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists |
| 08/23/2000 | CN1264380A 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1H)-one derivatives |
| 08/23/2000 | CN1264379A Piperazine derivatives |
| 08/23/2000 | CN1264378A Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists |
| 08/23/2000 | CN1264377A Substituted pyrazoles as P38 kinase inhabitors |
| 08/23/2000 | CN1264376A 3(5)-Heteroaryl substituted pyrazoles as P38 kinase inhibitors |
| 08/23/2000 | CN1264375A Crystal modification of N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 08/23/2000 | CN1264371A Pyrazine derivatives, their preparation and medicines containing them |
| 08/23/2000 | CN1264370A Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them |
| 08/23/2000 | CN1264369A Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them |
| 08/23/2000 | CN1264368A Polyhydroxybutylpyrazines, their preparation and medicines containing them |
| 08/23/2000 | CN1264366A Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy) ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
| 08/23/2000 | CN1264365A 3-benzoylindole derivatives and drugs containing the same |
| 08/23/2000 | CN1264363A Tramadol, salts thereof and process for their preparation |
| 08/23/2000 | CN1264321A Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strenght, and superabsorbent properties |
| 08/23/2000 | CN1264310A Polymer based pharmaceutical compositions for targeted delivery of biologically active agents |
| 08/23/2000 | CN1264308A Medicinal compositions for treating immunodeficinecy diseases |
| 08/23/2000 | CN1264304A Lipid-based immune modulator composition |
| 08/23/2000 | CN1264303A Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide |